[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.21.0″ text_orientation=”justified” hover_enabled=”0″ use_border_color=”off” border_color=”#000000″ border_style=”solid” saved_tabs=”all” global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
<\/p>\n
Luiz Felippe Mendes Caquetti<\/em><\/p>\n This case study assesses the effectiveness of treatment with ozonized injectable fibrin-rich plasma in a juvenile athlete with a muscle injury, aiming to accelerate tissue recovery and reduce downtime. The injury, characterized by intense pain and functional limitation in the left arm, was treated with two sessions of ozonized plasma. The process involved the collection and preparation of ozonized injectable fibrin-rich plasma, followed by ozonation and direct application to the injury under ultrasound guidance. Clinical and imaging evaluations conducted before and after treatment showed significant improvement in pain and muscle functionality, with the patient returning to sports activities without restrictions after two weeks. The results suggest that ozonized injectable fibrin-rich plasma may offer an effective and minimally invasive alternative for the treatment of muscle injuries in athletes, enhancing natural healing and tissue regeneration mechanisms. This case highlights the need for additional studies to validate the efficacy and safety of ozonized injectable fibrin-rich plasma in a broader clinical context..<\/em><\/p>\n <\/p>\nAbstract<\/strong><\/h3>\n